Prot #CA013-004: A Phase 1/2a Study of BMS-986179 Administered Alone and in Combination with Nivolumab (BMS-936558) in Subjects with Advanced Solid Tumors

Project: Research project

Project Details

StatusActive
Effective start/end date3/10/203/10/23

Funding

  • Bristol-Myers Squibb Company (Prot #CA013-004)